PMU19 FIRST LINE TREATMENT WITH NATALIZUMAB REDUCES HEALTHCARE RESOURCE USE AND IMPAIRMENT OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS COMPARED TO NATALIZUMAB DELAYED USE

Authors
Category Primary study
JournalValue Health
Year 2020
This article has no abstract
Epistemonikos ID: 36c4ac1e9ca9cd0e01d6ef4323ff4b521a1d6445
First added on: May 20, 2020